Molecular signature of persistent histological inflammation iulcerative colitis with mucosal healing

10Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Background & Aims: Therapeutic targets in ulcerative colitis (UC) have evolved over time from clinical remission to biological and endoscopic remission. Histologic remission remains a debatable outcome due to lack of data regarding its impact on long-term evolution. The development of histologic activity scores has brought standardization. We aimed to identify mucosal markers differentiating histological inflammation from histological remission in UC patients. Methods: The gene expression levels of 84 genes associated with inflammatory bowel diseases have been analyzed in 43 colonic mucosa samples from 30 patients with UC. The gene expression levels have been correlated with histological inflammation score of Geboes. Patients with endoscopic remission were divided by histological activity into two groups and molecular results were compared in order to identify differences in the mucosal gene expression. Results: We found a significant Pearson correlation (p<0.001 and r>0.5) between the Geboes score and the expression of 29 genes, whereas negative correlation (p<0.001 and r

Cite

CITATION STYLE

APA

Manuc, M., Ionescu, E. M., Milanesi, E., Dobre, M., Tieranu, I., Manuc, T. E., … Becheanu, G. (2020). Molecular signature of persistent histological inflammation iulcerative colitis with mucosal healing. Journal of Gastrointestinal and Liver Diseases, 29(2), 159–166. https://doi.org/10.15403/jgld-576

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free